FR2338271A1 - Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives - Google Patents

Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives

Info

Publication number
FR2338271A1
FR2338271A1 FR7701079A FR7701079A FR2338271A1 FR 2338271 A1 FR2338271 A1 FR 2338271A1 FR 7701079 A FR7701079 A FR 7701079A FR 7701079 A FR7701079 A FR 7701079A FR 2338271 A1 FR2338271 A1 FR 2338271A1
Authority
FR
France
Prior art keywords
derivatives
phthalane
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7701079A
Other languages
English (en)
Other versions
FR2338271B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kefalas AS
Original Assignee
Kefalas AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9722860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2338271(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kefalas AS filed Critical Kefalas AS
Publication of FR2338271A1 publication Critical patent/FR2338271A1/fr
Application granted granted Critical
Publication of FR2338271B1 publication Critical patent/FR2338271B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7701079A 1976-01-14 1977-01-14 Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives Granted FR2338271A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1486/76A GB1526331A (en) 1976-01-14 1976-01-14 Phthalanes

Publications (2)

Publication Number Publication Date
FR2338271A1 true FR2338271A1 (fr) 1977-08-12
FR2338271B1 FR2338271B1 (fr) 1982-11-05

Family

ID=9722860

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7701079A Granted FR2338271A1 (fr) 1976-01-14 1977-01-14 Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives

Country Status (19)

Country Link
US (1) US4136193A (fr)
JP (1) JPS52105162A (fr)
AT (1) AT359488B (fr)
AU (1) AU509445B2 (fr)
BE (1) BE850401A (fr)
CA (1) CA1094087A (fr)
CH (3) CH626886A5 (fr)
DE (1) DE2657013C2 (fr)
DK (1) DK143275C (fr)
ES (1) ES454980A1 (fr)
FI (1) FI63754C (fr)
FR (1) FR2338271A1 (fr)
GB (1) GB1526331A (fr)
IE (1) IE44055B1 (fr)
NL (2) NL192451C (fr)
NO (2) NO147243C (fr)
NZ (1) NZ183001A (fr)
SE (1) SE429551B (fr)
ZA (1) ZA7757B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087081A1 (fr) * 2002-04-09 2003-10-23 Torcan Chemical Ltd. Procede et produits intermediaires pour preparer l'escitalopram

Families Citing this family (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602035A (en) * 1983-12-07 1986-07-22 Hoechst-Roussel Pharmaceuticals Inc. Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
EP0759299B1 (fr) * 1995-08-16 2000-04-26 Eli Lilly And Company Potentialisation de la sérotonine
KR100357975B1 (ko) * 1997-07-08 2002-10-25 하. 룬트벡 아크티에 셀스카브 시탈로프램의 제조방법
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CN1286687A (zh) 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
DE69904853T2 (de) 1998-10-20 2003-09-04 Lundbeck As Valby H Verfahren zur herstellung von citalopram
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
KR20010081071A (ko) 1998-12-08 2001-08-25 피터슨 존 메이달 벤조푸란 유도체, 그것들의 제조 및 사용
CA2356188C (fr) 1998-12-23 2006-05-23 H. Lundbeck A/S Technique de preparation de 5-cyanophtalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
NZ514671A (en) * 1999-04-14 2003-10-31 H Method for the preparation of citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) * 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
ES2229774T3 (es) 1999-10-25 2005-04-16 H. Lundbeck A/S Metodo para la preparacion de citalopram.
DK1228056T3 (da) 1999-10-25 2005-01-24 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
JP2003519136A (ja) 1999-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
DE69912652T2 (de) * 1999-12-30 2004-06-09 H. Lundbeck A/S Verfahren zur herstellung von citalopram
SI1254129T1 (en) * 2000-01-14 2004-02-29 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
US6433196B1 (en) 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
FR2805812A1 (fr) * 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
IES20010143A2 (en) * 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
NZ521201A (en) * 2000-03-13 2004-02-27 H Method for the preparation of citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
EP1265881A1 (fr) * 2000-03-13 2002-12-18 H. Lundbeck A/S Alkylation progressive de 1-(4-fluorophenyl)-1,3-dihydroisobenzofuranes 5-substitues
MXPA02008653A (es) 2000-03-14 2003-02-24 Lundbeck & Co As H Metodo para la preparacion de citalopram.
JP2003527388A (ja) * 2000-03-16 2003-09-16 ハー・ルンドベック・アクチエゼルスカベット ５−シアノ−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフランの製造方法
EP1284729A4 (fr) * 2000-04-13 2007-12-19 Mayo Foundation Agents de reduction de a(beta)42
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) * 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
KR100821912B1 (ko) * 2000-05-12 2008-04-16 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조 방법
CA2383963A1 (fr) * 2000-07-06 2002-01-17 Eva Bolzonella Procede de preparation de citaloprame
PT1301502E (pt) * 2000-07-21 2005-09-30 Lundbeck & Co As H Compostos e sua utilizacao como inibidores do transporte de glicina
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
CA2354877C (fr) * 2000-08-18 2006-05-02 H. Lundbeck A/S Methode de preparation de citalopram
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
IT1319686B1 (it) * 2000-12-12 2003-10-23 C D Farmasint S R L Procedimento di preparazione di citalopram.
NL1017525C1 (nl) 2000-12-22 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van zuiver Citalopram
DE10112828C1 (de) * 2000-12-28 2002-11-21 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram
DE10164725B4 (de) * 2000-12-28 2004-08-26 H. Lundbeck A/S Verfahren zur Herstellung von gereinigtem Citalopram
IL147162A0 (en) * 2000-12-28 2002-08-14 Lundbeck & Co As H Process for the preparation of pure citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
EP1355897A1 (fr) * 2001-01-30 2003-10-29 Orion Corporation Fermion Procede de preparation de 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
US20040133017A1 (en) * 2001-02-22 2004-07-08 Pulla Reddy Muddasani Process for the preparation of citalopram
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
JP2005500256A (ja) * 2001-03-09 2005-01-06 ランバクシー ラボラトリーズ リミテッド シタロプラム製造方法
CZ20033267A3 (en) * 2001-05-01 2004-06-16 H. Lundbeck A/S The use of enantiomeric pure escitalopram
BG65271B1 (bg) * 2001-06-18 2007-11-30 H. Lundbeck A/S Метод за получаване на циталопрам
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IN192057B (fr) * 2001-07-19 2004-02-14 Ranbaxy Lab Ltd
DK1414435T3 (da) * 2001-07-31 2005-05-09 Lundbeck & Co As H Krystallinsk komposition indeholdende escitalopram
EP1288211A1 (fr) * 2001-08-28 2003-03-05 Sekhsaria Chemicals Ltd. Procédé amélioré pour la préparation d'hydrobromure de Citalopram à partir de 5-bromophthalide
US6967259B2 (en) * 2001-09-24 2005-11-22 Pharmachem Technologies Limited Process for the preparation of Citalopram intermediate
ES2666188T3 (es) * 2001-10-12 2018-05-03 Azevan Pharmaceuticals, Inc. Antagonistas del v1a de vasopresina beta-lactámicos
IN192863B (fr) * 2001-11-13 2004-05-22 Ranbaxy Lab Ltd
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
AU2003222435A1 (en) * 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
GB2387844B (en) * 2002-02-27 2005-05-11 Matrix Lab Ltd Separation of impurities from a crude mixture of citalopram
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
EP1346989A1 (fr) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Procede ameliore de preparation de citalopram et de bromhydrate de citalopram
EP1496044B1 (fr) * 2002-03-27 2010-11-03 Bando Chemical Industries, Ltd. Nouveau 1,3,5-tris(arylamino)benzene
FI20021421A0 (fi) * 2002-07-30 2002-07-30 Orion Corp Fermion Valmistusmenetelmä
AR040970A1 (es) * 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
WO2004016602A1 (fr) * 2002-08-14 2004-02-26 Natco Pharma Limited Procede de preparation de citalopram haute purete et de ses sels pharmaceutiquement acceptables
GB2385051B (en) * 2002-08-29 2003-12-24 Max India Ltd Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
KR20050086933A (ko) * 2002-12-23 2005-08-30 하. 룬트벡 아크티에 셀스카브 브롬화수소산에스시탈로프람 및 이의 제조방법
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
WO2004065375A1 (fr) * 2003-01-17 2004-08-05 Natco Pharma Limited Procede de preparation d'escitalopram et de son precurseur
WO2004071431A2 (fr) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Composition et methode de traitement de troubles neurodegeneratifs
ITMI20030479A1 (it) * 2003-03-13 2004-09-14 Adorkem Technology S P A Procedimento per la preparazione di un ciano-isobenzofurano.
US7019153B2 (en) * 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
WO2005065069A2 (fr) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer
GB0317475D0 (en) * 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
ITFI20030202A1 (it) * 2003-07-28 2005-01-29 Synteco Spa Processo per la preparazione di derivati del
PT1668014E (pt) * 2003-09-17 2009-03-17 Janssen Pharmaceutica Nv Compostos heterocíclicos fundidos como moduladores do receptor de serotonina
WO2005042473A1 (fr) * 2003-10-28 2005-05-12 Wockhardt Limited Procede ameliore de preparation d'hydrobromure de citalopram
DK1506963T3 (da) * 2003-10-28 2005-08-01 Adorkem Technology Spa Fremgangsmåde til fremstilling af citalopram
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
EP2272514A1 (fr) * 2003-12-02 2011-01-12 PharmaNeuroBoost N.V. Utilisation d'une faible dose de pipamperone et d'un deuxième agent actif dans le traitement des maladies neurodégénératives
WO2005060968A1 (fr) 2003-12-11 2005-07-07 Sepracor Inc. Combinaison d'un sedatif et d'un modulateur des neurotransmetteurs, et methodes permettant d'ameliorer la qualite du sommeil et de traiter la depression
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
CA2559703A1 (fr) * 2004-02-16 2005-08-25 Jubilant Organosys Limited Synthese one pot de citalopram a partir de 5-cyanophthalide
US20050196453A1 (en) * 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (it) * 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
EP1737473A4 (fr) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Combinaisons de lithium et utilisations associees
CN1946906A (zh) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 用于墙、护墙和类似物的饰面
WO2006020852A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs
WO2006020850A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs
WO2006020853A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et methode de traitement de troubles neurodegeneratifs
WO2006021971A2 (fr) * 2004-08-23 2006-03-02 Sun Pharmaceutical Industries Limited Procede de preparation de citalopram et d'enantiomeres
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
EP1868434A4 (fr) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc Acides beta-lactamylalcanoiques destines au traitement des troubles premenstruels
WO2006103550A1 (fr) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processus de preparation du citalopram et son intermediaire, le 5-aminophthalide
TW200718692A (en) 2005-04-22 2007-05-16 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
CN101203216A (zh) * 2005-04-22 2008-06-18 惠氏公司 二氢苯并呋喃衍生物及其用途
CN101163689A (zh) * 2005-04-22 2008-04-16 惠氏公司 {[(2r)-7-(2，6-二氯苯基)-5-氟-2，3-二氢-1-苯并呋喃-2-基]甲基}胺盐酸盐的晶形
CN101203218A (zh) * 2005-04-22 2008-06-18 惠氏公司 苯并呋喃基链烷胺衍生物和其作为5－ht2c激动剂的用途
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
EP1904843A2 (fr) * 2005-07-08 2008-04-02 Braincells, Inc. Methodes destinees a identifier des agents et des conditions modulant la neurogenese
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
CN101268068B (zh) * 2005-07-19 2015-12-02 阿泽范药品公司 β-内酰胺基苯丙氨酸、半胱氨酸和丝氨酸血管加压素拮抗剂
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
JP2009515840A (ja) * 2005-11-14 2009-04-16 ハー・ルンドベック・アクチエゼルスカベット エスシタロプラムの製造方法
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
EP1991212A1 (fr) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation de neurogenèse par des agents nootropes
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
KR20080105104A (ko) * 2006-03-24 2008-12-03 와이어쓰 우울증 치료를 위한 신규한 치료학적 병용제
MX2008014320A (es) * 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
WO2008059514A2 (fr) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Procédé de préparation d'escitalopram
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2663347A1 (fr) * 2006-09-19 2008-03-27 Braincells, Inc. Modulation induite par ppar de la neurogenese
JP4927497B2 (ja) * 2006-10-25 2012-05-09 株式会社シスコ 無湿乾燥用ホッパー装置
CN100457747C (zh) * 2006-11-21 2009-02-04 浙江大学 抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
CA2675132A1 (fr) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation de la neurogenese en utilisant du modafinil
EP1988086B2 (fr) 2007-04-23 2014-11-26 Synthon B.V. Processus pour résoudre un citalopram
NZ580738A (en) * 2007-05-18 2012-02-24 Cipla Ltd Process for the preparation of escitalopram
US20080312318A1 (en) * 2007-06-14 2008-12-18 Protia, Llc Deuterium-enriched escitalopram
EP2017271A1 (fr) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Procédé de préparation d'escitalopram
US8022232B2 (en) * 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
KR101103118B1 (ko) * 2007-11-02 2012-01-04 동아제약주식회사 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
EP2288345B1 (fr) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Produits psycho-pharmaceutiques
EP2116231A1 (fr) 2008-05-07 2009-11-11 Hexal Ag Granulé comprenant de l'oxalate d'escitalopram
US20100087664A1 (en) * 2008-10-07 2010-04-08 Ravindra Vedantham Preparation of citalopram and salts thereof
GR20080100696A (el) 2008-10-23 2010-05-13 Genepharm �.�. Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
PL3093291T3 (pl) 2009-10-23 2019-11-29 Janssen Pharmaceutica Nv Dipodstawione oktahydropirolo[3,4-c]pirole jako modulatory receptora oreksyny
JP2013535425A (ja) 2010-07-01 2013-09-12 アゼヴァン ファーマシューティカルズ，インコーポレイテッド 心的外傷後ストレス障害を治療する方法
WO2013100870A1 (fr) 2011-12-02 2013-07-04 Mahmut Bilgic Nouvelles compositions antipsychotiques
WO2013081567A1 (fr) 2011-12-02 2013-06-06 Mahmut Bilgic Formulations antipsychotiques effervescentes
WO2013110313A1 (fr) * 2012-01-23 2013-08-01 H. Lundbeck A/S Modulateurs allostériques sélectifs du transporteur de la sérotonine
MX2016012645A (es) 2014-03-28 2017-01-11 Azevan Pharmaceuticals Inc Composiciones y metodos para tratar enfermedades neurodegenerativas.
ES2913469T3 (es) * 2016-03-10 2022-06-02 Janssen Pharmaceutica Nv Métodos para tratar la depresión usando antagonistas del receptor de orexina-2
AU2018333051B2 (en) 2017-09-15 2024-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (fr) * 1965-03-18

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087081A1 (fr) * 2002-04-09 2003-10-23 Torcan Chemical Ltd. Procede et produits intermediaires pour preparer l'escitalopram

Also Published As

Publication number Publication date
CA1094087A (fr) 1981-01-20
BE850401A (fr) 1977-07-14
JPS6135986B2 (fr) 1986-08-15
NO147243C (no) 1983-03-02
SE7614201L (sv) 1977-07-15
FR2338271B1 (fr) 1982-11-05
DE2657013C2 (de) 1985-11-14
DK143275C (da) 1982-01-18
ES454980A1 (es) 1978-04-01
IE44055L (en) 1977-07-14
NL192451C (nl) 1997-08-04
JPS52105162A (en) 1977-09-03
IE44055B1 (en) 1981-07-29
NL7700244A (nl) 1977-07-18
FI770073A (fr) 1977-07-15
GB1526331A (en) 1978-09-27
NO1996001I1 (no) 1996-01-05
FI63754C (fi) 1983-08-10
CH632259A5 (de) 1982-09-30
FI63754B (fi) 1983-04-29
NO770109L (no) 1977-07-15
US4136193A (en) 1979-01-23
AT359488B (de) 1980-11-10
DK13177A (da) 1977-07-15
DE2657013A1 (de) 1977-07-28
SE429551B (sv) 1983-09-12
AU509445B2 (en) 1980-05-15
CH632258A5 (de) 1982-09-30
DK143275B (da) 1981-08-03
ZA7757B (en) 1977-11-30
NL192451B (nl) 1997-04-01
NL970031I1 (nl) 1997-10-01
NL970031I2 (nl) 1997-10-01
AU2107377A (en) 1978-07-13
ATA947276A (de) 1980-04-15
CH626886A5 (fr) 1981-12-15
NO147243B (no) 1982-11-22
NZ183001A (en) 1978-06-02

Similar Documents

Publication Publication Date Title
FR2338271A1 (fr) Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
FR2331340A1 (fr) Nouveaux derives du benzimidazole, procede pour leur obtention et compositions pharmaceutiques les contenant
BE855032A (fr) Compositions pharmaceutiques pour opacification barytee et leur procede de preparation
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
BE868796A (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
BE849810A (fr) Nouvelles pyrimidones, procede pour les preparation et compositions pharmaceutiques les contenant
BE858283A (fr) Nouveaux derives de perhydro-aza-heterocycles utiles comme medicaments et procede pour leur preparation
BE858134A (fr) Nouveaux derives de 0-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques
BE837848A (fr) Thiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant
BE857138A (fr) Derives peptidiques, procede pour leur preparation et compositions therapeutiques contenant ces composes
BE835744A (fr) Derives de 5,7-dihydroxytetraisoquinoline, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
BE884101A (fr) Derives d'isoquinoleine contenant du soufre, procedes pour leur preparation et composition pharmaceutiques les contenant
FR2304343A1 (fr) Nouvelles cephalosporines, procede pour leur obtention et compositions pharmaceutiques les contenant
BE875091A (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
FR2322591A1 (fr) Arylalkylamides, presentant une activite antidepressive, procede pour leur obtention et compositions pharmaceutiques les contenant
BE848909A (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
FR2347338A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et compositions pharmaceutiques les contenant
BE826711A (fr) Derives d'indolylacetylamino-acide, leur procede de preparation et les compositions pharmaceutiques contenant ces composes
FR2274291A1 (fr) Nouvelles compositions pharmaceutiques et procede pour leur preparation
PT65151A (fr) Procede pour la preparation de nouvelles solutions pharmaceutiques stables
BE869834A (fr) Nouveaux derives de 3-amino-17a-aza-d-homo-androstane, leur procede de preparation et les compositions pharmaceutiques les contenant
BE880492Q (fr) Derives de 1,3-dioxolane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
FR2467204B1 (fr) Derives de 1,2,4-oxadiazine, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: CITALOPRAM BROMHYDRATE; NAT. REGISTRATION NO/DATE: NL 16222 19941226; FIRST REGISTRATION: DK - 6742 20100217

Spc suppl protection certif: 95C0009

Filing date: 19950414

CP Supplementary protection certificate (spc) filed

Free format text: 95C0009, 950414

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 95C0009, 950414

CP Supplementary protection certificate (spc) filed
CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 95C0009, 950414 EXPIRES:20020113

CP Supplementary protection certificate (spc) filed